Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
KCNQ3
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3) ==Publications== {{medline-entry |title=Age-dependent modulation of hippocampal excitability by KCNQ-channels. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/12576170 |abstract=Recently, mutations of [[KCNQ2]] or [[KCNQ3]], members of the KCNQ-related K( )-channel (KCNQ-channel) family, were identified as cause of benign familial neonatal convulsions (BFNC). However, the exact pathogenic mechanisms of age-dependent development and spontaneous remission of BFNC remain to be elucidated. To clarify the age-dependent etiology of BFNC, we determined age-dependent functional switching of KCNQ-channels, GABAergic- and glutamatergic-transmission in rat hippocampus. The effects of inhibitors of KCNQ-channel, GABA- and glutamate-receptors on propagation of neuronal-excitability and neurotransmitter release were determined by 64-channel multielectrode-dish (MED64), whole-cell recording, in vitro release technique and in vivo microdialysis biosensor, using rat hippocampus from day of birth (P0) to postnatal-day 56 (P56). Inhibition of KCNQ-channels enhanced depolarization-induced glutamate and GABA releases during P0-P7, but not during P14-P28. Inhibition of KCNQ-channels magnified neuronal-excitability propagation from P0 to P14: maximal at P3, but this effect disappeared by P28. GABA(A)-receptor inhibition surprisingly reduced neuronal-excitability propagation during P0-P3, but not at P7. AMPA/glutamate-receptors inhibition reduced propagation of neuronal-excitability throughout the study period. KCNQ-channels inhibition shortened spike-frequency adaptation, but this stimulation was more predominant during P<7 than P>14. During the first week of life, KCNQ-channels performed as a predominant inhibitory system, whereas after this period GABAergic-transmission switched from excitatory to inhibitory function. Contrary, glutamatergic-transmission has acquired as excitatory function from P0. These findings suggest that the pathogenic mechanisms of age-dependent development and spontaneous remission of BFNC are, at least partially, associated with the interaction between age-dependent reduction of inhibitory KCNQ-channel activity and age-dependent functional switching of the GABAergic-system from excitatory to inhibitory action in neonatal CNS. |mesh-terms=* Aging * Animals * Biosensing Techniques * Cortical Spreading Depression * Epilepsy, Benign Neonatal * Glutamic Acid * Hippocampus * Male * Membrane Potentials * Microdialysis * Neurons * Neurotransmitter Agents * Potassium * Potassium Channels * Rats * Rats, Wistar * Remission, Spontaneous * Synaptic Transmission * gamma-Aminobutyric Acid |full-text-url=https://sci-hub.do/10.1016/s0920-1211(02)00249-8 }} {{medline-entry |title=The [[KCNQ2]] potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with [[KCNQ3]]. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/9827540 |abstract=Benign familial neonatal convulsions, an autosomal dominant epilepsy of newborns, are linked to mutations affecting two six-transmembrane potassium channels, [[KCNQ2]] and [[KCNQ3]]. We isolated four splice variants of [[KCNQ2]] in human brain. Two forms generate, after transient expression in COS cells, a potassium-selective current similar to the [[KCNQ1]] current. L-735,821, a benzodiazepine molecule which inhibits the [[KCNQ1]] channel activity (EC50 = 0.08 microM), also blocks [[KCNQ2]] currents (EC50 = 1.5 microM). Using in situ hybridization, [[KCNQ2]] and [[KCNQ3]] have been localized within the central nervous system, in which they are expressed in the same areas, mainly in the hippocampus, the neocortex and the cerebellar cortex. During brain development, [[KCNQ3]] is expressed later than [[KCNQ2]]. |mesh-terms=* Aging * Alternative Splicing * Amino Acid Sequence * Animals * Benzodiazepines * Brain * COS Cells * Gene Expression Regulation * Gene Expression Regulation, Developmental * Genetic Variation * Humans * In Situ Hybridization * KCNQ2 Potassium Channel * KCNQ3 Potassium Channel * Mice * Molecular Sequence Data * Organ Specificity * Potassium Channels * Potassium Channels, Voltage-Gated * RNA, Messenger * Recombinant Proteins * Transcription, Genetic * Transfection |full-text-url=https://sci-hub.do/10.1016/s0014-5793(98)01296-4 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)